Fig. 5 E, F

Pandey A et al. (2023)

Xla Wt + adam11 MO + cranial neural crest transplant

NF17 (western blot)

Expression Phenotype
decreased amount cdh1.L expression in cranial neural crest increased amount cdh2.L expression in cranial neural crest

XB-PHENO-25468

Nagel M et al. (2021)

Xla Wt + BCR removal + KD-Pak1

NF10.5

Expression Phenotype
mislocalised cdh1.L expression in involuted dorsal mesoderm mislocalised fn1.L expression in involuted dorsal mesoderm

XB-PHENO-25458

Nagel M et al. (2021)

Xla Wt + KD-Pak1

NF10.5

Expression Phenotype
mislocalised cdh1.L expression in involuted dorsal mesoderm

Fig.7.C

Alharatani R et al. (2020)

Xtr Wt + ctnnd1 CRISPR

NF11 (immunohistochemistry)

Expression Phenotype
decreased amount cdh1 expression in plasma membrane

Fig. 6 I I' I''

Bharathan NK and Dickinson AJG (2019)

Xla Wt + dsp MO

NF22 (immunohistochemistry)

Anatomical Phenotype
abnormal epidermis morphology

Expression Phenotype
decreased amount cdh1.L expression in epidermis

skin disease

Fig. 3 MO

Davis A et al. (2017)

Xla Wt + SB505124

NF39 (immunohistochemistry)

Expression Phenotype
absent cdh1.L expression in stomach epithelium absent pard3.L expression in stomach epithelium

fig.5.a

Wang S et al. (2013)

Xla Wt + pard6b MO

NF12 (immunohistochemistry)

Expression Phenotype
decreased amount cdh1.L expression in embryo decreased amount cdh3.L expression in embryo

Fig 4 A A^1 B B^1

Wang S et al. (2013)

Xla Wt + pard6b MO

NF15 (immunohistochemistry)

Expression Phenotype
decreased amount cdh1.L expression in epidermis

fig.5.a

Wang S et al. (2013)

Xla Wt + pard6b MO

NF16 (immunohistochemistry)

Expression Phenotype
decreased amount cdh1.L expression in embryo decreased amount cdh3.L expression in embryo

fig.5.a

Wang S et al. (2013)

Xla Wt + pard6b MO

NF19 (immunohistochemistry)

Expression Phenotype
decreased amount cdh1.L expression in embryo decreased amount cdh3.L expression in embryo